إعلان
إعلان
TSHA
Taysha Gene Therapies, Inc. Common Stock
4.97
USDبرعاية
-0.17
-3.37%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
4.94
-0.03
-0.54%
تقارير أرباح TSHA
النسبة الإيجابية المفاجئة
TSHA تفوق 10 من 21 آخر التقديرات.
48%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$2.10M
/-$0.09
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/--
التغير الضمني من Q4 24 (Revenue/ EPS)
+3.95%
/+28.57%
Taysha Gene Therapies, Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, TSHA reported earnings of -0.09 USD per share (EPS) for Q3 25, Inline the estimate of -0.09 USD, resulting in a 0.00% surprise. Revenue reached --, compared to an expected 1.41 مليون, with a -100.00% difference. The market reacted with a -4.26% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 المحللين forecast an EPS of -0.09 USD, with revenue projected to reach 2.10 مليون USD, implying an زيادة of 0.00% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Taysha Gene Therapies, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Taysha Gene Therapies, Inc. Common Stock reported EPS of -$0.09, missing estimates by 0%, and revenue of $0.00, -100% below expectations.
How did the market react to Taysha Gene Therapies, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.26%, changed from $4.46 before the earnings release to $4.27 the day after.
When is Taysha Gene Therapies, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Taysha Gene Therapies, Inc. Common Stock's next earnings report?
Based on 15
المحللين, Taysha Gene Therapies, Inc. Common Stock is expected to report EPS of -$0.09 and revenue of $2.10M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان